Cascadian Therapeutics Inc. (CASC): Seth Klarman Took A Victory Lap
Value investor Seth Klarman disclosed in a recent 13G filing that it tendered all of its 8.7 million stake in Cascadian Therapeutics Inc. (CASC).
April 11th, 2018 - Hedge Funds News
December 9th, 2017 - Hedge Funds
October 11th, 2017 - Hedge Funds
May 9th, 2017 - Hedge Funds
April 19th, 2017 - Hedge Funds News
February 7th, 2017 - Hedge Funds
February 2nd, 2017 - Hedge Funds News
December 15th, 2016 - Hedge Funds News
December 13th, 2016 - Hedge Funds News
October 18th, 2016 - Hedge Funds
Returns since its inception in May 2014 (through February 19th, 2025)